TCM doesn’t seem all that hard to comprehend to me.
But what you have failed to understand is that stems need to be administered early. Before you get really sick. Otherwise, as you know, they are not effective ( as the MSB trials have demonstrated). That means, you need to administer to people who will never need it. Like not everyone who gets the flu jab will have gotten really sick.
That means when calculating the cost of the treatment you need to include the cost of treating the people who would have recovered quite nicely without stems. And the cost of stems is seriously high compared to many other effective treatments. That is why it is not economically rational to use stems of Covid.
Plus, by the time MSB get approval, there will be other effective cheep alternatives which will be better at treating Covid.
Ann: COVID ARDS Trial Topline 60-Day Results, page-307
-
- There are more pages in this discussion • 1,322 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |